A61P 1/18

Technology



back to "A61P 1/18" profile

More Results

Showing 1 to 20 of 21 results

Patent/Pub #TitleFiling DateIssue/Publication DatePatent Owner
9861669 Oncolytic virotherapy for prevention of tumor recurrenceMay 19, 10Jan 09, 18DEUTSCHES KREBSFORSCHUNGSZENTRUM, RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG,
9566366 Multiple-layer immune barrier for donor cellsAug 10, 16Feb 14, 17BETA-O2 TECHNOLOGIES LTD.
9446168 Multiple-layer immune barrier for donor cellsJun 06, 11Sep 20, 16BETA-O2 TECHNOLOGIES LTD.
9393315 Compounds for targeting drug delivery and enhancing siRNA activityJun 08, 12Jul 19, 16NITTO DENKO CORPORATION
8975228 Use of boswellic acids for the prophylaxis and/or treatment of damage to and/or inflammation of the islets of LangerhansSep 22, 11Mar 10, 15FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
8889715 Substituted pyridoxine-lactam carboxylate saltsNov 02, 12Nov 18, 14ALCOBRA LTD.
8846761 Method for treating pancreatitisDec 22, 11Sep 30, 14GEMPHIRE THERAPEUTICS INC.
8784884 Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiencySep 28, 09Jul 22, 14ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
8785433 Quinoline derivatives as PI3 kinase inhibitorsDec 12, 13Jul 22, 14GLAXOSMITHKLINE LLC
8754037 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing sameDec 21, 11Jun 17, 14HANALL BIOPHARMA CO., LTD.
8633184 Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterolJan 19, 10Jan 21, 14JANSSEN PHARMACEUTICA NV
8618045 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing sameDec 21, 11Dec 31, 13HANALL BIOPHARMA CO., LTD.
8575091 Amylin analogues and pharmaceutical compositions thereofJun 28, 13Nov 05, 13NOVO NORDISK A/S
8506997 Pharmaceutical compound containing silymarin and carbopol, its manufacturing process and its use as a regenerator of the pancreatic tissue and cells of endogenous secretion damaged by diabetes mellitusMay 01, 09Aug 13, 13Universidad Autonoma Metropolitana
8414883 Parvovirus cancer therapy and combination with chemotherapyDec 23, 08Apr 09, 13DEUTSCHES KREBSFORSCHUNGSZENTRUM, RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG,
8377894 Drug and food or drink for improving pancreatic functionsFeb 28, 06Feb 19, 13MORINAGA MILK INDUSTRY CO., LTD.
8288541 Piperazine amide derivativesAug 06, 08Oct 16, 12HOFFMANN-LA ROCHE INC.
8058289 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitorsOct 18, 10Nov 15, 11MERCK SERONO SA
8053434 Kinase inhibitors and their usesSep 01, 09Nov 08, 11RIGEL PHARMACEUTICALS, INC.
7842698 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitorsSep 02, 05Nov 30, 10MERCK SERONO SA

Showing 1 to 20 of 21 results